Omar Atiq invested in inaugural UAMS Omar T. Atiq Distinguished Chair in Physician Leadership

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Andrew M. EvensPhillip ScheinbergThe British Journal of Haematology announced the appointment of Andrew M. Evens as its editor-in-chief, effective Jan. 1, 2025.

December 06, 2024

Vol.50 No.45

Drugs & Targets

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

ConcertAI announced a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.

December 06, 2024

Vol.50 No.45

In Brief

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Thomas Bradley has been appointed director of hematology and oncology at Staten Island University Hospital’s Florina Cancer Center to spearhead the division’s clinical, educational, and research initiatives.

October 25, 2024

Vol.50 No.40

In Brief

UAMS Winthrop P. Rockefeller Cancer Institute named Center of Excellence by MDS Foundation

The University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute has been designated as a Center of Excellence by the MDS Foundation, making it the only center in Arkansas to become part of the foundation’s referral network of the top bone marrow disorder treatment centers in the world.

October 18, 2024

Vol.50 No.39

In Brief

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Michael Seidman has joined Fox Chase Cancer Center as a professor in the Department of Hematology/Oncology.

August 09, 2024

Vol.50 No.32

Clinical Roundup

Bintrafusp alfa shows tumor response rate for patients with recurrent or metastatic cervical cancer

Bintrafusp alfa, a novel bispecific antibody, achieved an objective response rate of 22% in women with recurrent or metastatic cervical cancer in a phase II nonrandomized controlled trial.

July 26, 2024

Vol.50 No.30

Omar Atiq invested in inaugural UAMS Omar T. Atiq Distinguished Chair in Physician Leadership

YOU MAY BE INTERESTED IN

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

UAMS Winthrop P. Rockefeller Cancer Institute named Center of Excellence by MDS Foundation

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Bintrafusp alfa shows tumor response rate for patients with recurrent or metastatic cervical cancer

Renew today!

Subscriber content

Never miss an issue!

Login